Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Osteoporosis International
Published in: Osteoporosis International 11/2014

01-11-2014 | Original Article

Patient perceptions of provider barriers to post-fracture secondary prevention

Authors: J. E. M. Sale, E. Bogoch, G. Hawker, M. Gignac, D. Beaton, S. Jaglal, L. Frankel

Published in: Osteoporosis International | Issue 11/2014

Login to get access

Abstract

Summary

We examined patients’ experiences regarding bone mineral density (BMD) testing and bone health treatment after being screened through Ontario’s Fracture Clinic Screening Program. Provider-level barriers to testing and treatment appeared to be as significant as patient-level barriers and potentially had more of an impact on treatment than on testing.

Introduction

Post-fracture secondary prevention programs have had modest effects on bone densitometry rates and osteoporosis (OP) treatment initiation. Few studies have examined in depth the reasons that patients choose to seek or avoid investigation and treatment after screening through such a program. Our purpose was to examine patients’ experiences regarding bone mineral density (BMD) testing and bone health treatment after screening through Ontario’s Fracture Clinic Screening Program (FCSP).

Methods

We conducted a prospective qualitative study in fragility fracture patients screened through one site of the FCSP. Eligible patients not on antiresorptive medication at the time of fracture were assessed by an osteoporosis screening coordinator and advised to follow up with their primary care physician for a BMD test and appropriate treatment. Participants were interviewed within 6, and within 18, months of their clinic visit. Fracture risk was assessed by the study team. Interviews were transcribed verbatim and analyzed by two researchers.

Results

We conducted 51 interviews with 25 patients (22 females, 3 males) aged 50–79 years old, of whom 8 were deemed high risk for future fracture. Eighteen participants had a BMD test between baseline and follow-up and three reported receiving a prescription for pharmacotherapy. We categorized 21 participants as experiencing at least one barrier to BMD testing and appropriate treatment including health care providers telling participants that the fracture was not a fragility fracture, using participants’ appearance/demographic information and X-rays to judge bone density, telling participants that a BMD test was not appropriate, failing to discuss fracture risk status, and giving unclear or incorrect information about treatment.

Conclusion

We identified modifiable barriers to post-fracture secondary prevention from the patient’s perspective. Provider-level barriers appeare to be as significant as patient-level barriers and potentially had more of an impact on treatment than on BMD testing.
Literature
1.
Sale JEM, Beaton D, Posen J, Elliot-Gibson V, Bogoch E (2011) Systematic review on interventions to improve osteoporosis investigation and treatment in fragility fracture patients. Osteoporos Int 22(7):2067–82PubMedCrossRef
2.
Ganda KPM, Chen JS, Speerin R, Beasel J, Center JR, Eisman JA et al (2013) Models of care for the secondary prevention of osteoporotic fractures: A systematic review and meta-analysis . Osteoporos Int 24:393–406
3.
Little EA, Eccles MP (2010) A systematic review of the effectiveness of interventions to improve post-fracture investigation and management of patients at risk of osteoporosis. Implement Sci 5:80PubMedCrossRefPubMedCentral
4.
Beaton D, Dyer S, Jiang D, Sujic R, Slater M, Sale J et al (2013) Factors influencing the pharmacological management of osteoporosis after a fragility fracture: Results from the Ontario Osteoporosis Strategy's Fracture Clinic Screening Program. Osteoporos Int. doi:10.​1007/​s00198-013-2430-6
5.
Sale JEM, Beaton DE, Sujic R, Bogoch ER (2010) If it was osteoporosis, I would have really hurt myself. Ambiguity about osteoporosis and osteoporosis care despite a screening program to educate fracture patients. J Eval Clin Pract 16(3):590–6PubMed
6.
Sale JEM, Beaton D, Fraenkel L, Elliot-Gibson V, Bogoch E (2010) The BMD muddle: the disconnect between bone densitometry results and perception of bone health. J Clin Densitom 13(4):370–8PubMedCrossRef
7.
Sale J, Gignac M, Hawker G, Frankel L, Beaton D, Bogoch E et al (2011) Decision to take osteoporosis medication in patients who have had a fracture and are 'high' risk for future fracture. BMC Musculoskelet Disord 12:92
8.
Blonk MC, Erdtsieck RJ, Wernekinck MG, Schoon EJ (2007) The fracture and osteoporosis clinic: 1-year results and 3-month compliance. Bone 40(6):1643–9PubMedCrossRef
9.
Cuddihy MT, Amadio PC, Gabriel SE, Pankratz VS, Kurland RL, Melton LJ III (2004) A prospective clinical practice intervention to improve osteoporosis management following distal forearm fracture. Osteoporos Int 15(9):695–700PubMedCrossRef
10.
Astrand J, Thorngren KG, Tagil M (2006) One fracture is enough! Experience with a prospective and consecutive osteoporosis screening program with 239 fracture patients. Acta Orthop 77(1):3–8
11.
Tosi LL, Gliklich R, Kannan K, Koval KJ (2008) The American Orthopaedic Association's "own the bone" initiative to prevent secondary fractures. J Bone Joint Surg Am Vol 90(1):163–73CrossRef
12.
Schmid L, Henzen C, Schlumpf U, Babst R (2004) Improving secondary prevention in fragility fracture patients: the impact of a simple clinical information procedure. J Appl Res 4(4):570–5
13.
Majumdar SR, Johnson JA, McAlister FA, Bellerose D, Russell AS, Hanley DA et al (2008) Multifaceted intervention to improve diagnosis and treatment of osteoporosis in patients with recent wrist fracture: a randomized controlled trial. CMAJ 178(5):569–75
14.
Hegeman JH, Willemsen G, van Nieuwpoort J, Kreeftenberg HG, van der Veer E, Slaets JPJ et al (2005) Effective case-finding of osteoporosis in a Fracture and Osteoporosis Clinic in Groningen: an analysis of the first 100 patients. Aktuelle Traumatologie 35(1):34–39
15.
Harrington JT, Lease J (2007) Osteoporosis disease management for fragility fracture patients: new understandings based on three years' experience with an osteoporosis care service. Arthritis Rheum (Arthritis Care Res) 57(8):1502–6
16.
Jaglal SB, Hawker G, Bansod V, Salbach NM, Zwarenstein M, Carroll J et al (2009) A demonstration project of a multi-component educational intervention to improve integrated post-fracture osteoporosis care in five rural communities in Ontario, Canada. Osteoporos Int 20(2):265–74
17.
Harrington JT, Barash HL, Day S, Lease J (2005) Redesigning the care of fragility fracture patients to improve osteoporosis management: a health care improvement project. Arthritis Rheum 53(2):198–204PubMedCrossRef
18.
Ho C, Cranney A, Campbell A (2006) Measuring the impact of pharmacist intervention: results of patient education about osteoporosis after fragility fracture. Can J Hosp Pharm 59(4):184–93
19.
Gallacher SJ (2005) Setting up an osteoporosis fracture liaison service: background and potential outcomes. Best Pract Res Clin Rheumatol 6:1081–94CrossRef
20.
Bliuc D, Eisman JA, Center JR (2006) A randomized study of two different information-based interventions on the management of osteoporosis in minimal and moderate trauma fractures. Osteoporos Int 17(9):1309–17PubMedCrossRef
21.
Gardner MJ, Brophy RH, Demetrakopoulos D, Koob J, Hong R, Rana A et al (2005) Interventions to improve osteoporosis treatment following hip fracture. A prospective, randomized trial.[see comment]. J Bone Joint Surg Am 87(1):3–7
22.
Jaglal SB, Hawker G, Cameron C, Canavan J, Beaton D, Bogoch E et al (2010) The Ontario Osteoporosis Strategy: implementation of a population-based osteoporosis action plan in Canada. Osteoporos Int 21:903–8
23.
Papaioannou A, Leslie WD, Morin S, Atkinson S, Brown J, Cheung AM et al (2010) 2010 Clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. Can Med Assoc J 182(17):1864–73
24.
Morse JM (1994) Designing funded qualitative research. In: Denzin NK, Lincoln YS (eds) Handbook of qualitative research. Sage Publications, Inc, Thousand Oaks, pp 220–35
25.
Schwandt TA (2001) Dictionary of qualitative inquiry, 2nd edn. Sage Publications, Inc., Thousand Oaks
26.
27.
World Health Organization (1994) Assessment of fracture risk and application to screening for postmenopausal osteoporosis. WHO Technical Report Series, Geneva
28.
Papaioannou A, Morin S, Cheung AM, Atkinson S, Brown J, Feldman S et al (2010) Clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: Background and technical report. Osteoporosis Canada, Toronto
29.
Leslie WD, Berger C, Langsetmo L, Lix LM, Adachi JD, Hanley D et al (2011) Construction and validation of a simplified fracture risk assessment tool for Canadian women and men: Results from the CaMos and Manitoba cohorts. Osteoporos Int 22(6):1873–83
30.
Leslie WD, Lix LM, Johansson H, Oden A, McCloskey E, Kanis JA (2010) Independent clinical validation of a Canadian FRAX tool: fracture prediction and model calibration. J Bone Min Res 25(11):2350–8CrossRef
31.
Giorgi A (2008) Concerning a serious misunderstanding of the essence of the phenomenological method in psychology. J Phenomenol Psychol 39:33–58CrossRef
32.
Wertz FJ (2005) Phenomenological research methods for counseling psychology. J Couns Psychol 52(2):167–77CrossRef
33.
34.
Siminoski K, Leslie WD, Frame H, Hodsman A, Josse RG, Khan A et al (2005) Recommendations for bone mineral density reporting in Canada. Can Assoc Radiol J 56(3):178–88
35.
Giorgi A (1989) Some theoretical and practical issues regarding the psychological phenomenological method. Saybrook Rev 7:71–85
36.
Giorgi A (1997) The theory, practice, and evaluation of the phenomenological method as a qualitative research procedure. J Phenomenol Psychol 28:235–60CrossRef
37.
Polkinghorne DE (1989) Phenomenological research methods. In: Valle RS, Halling S (eds) Existential-phenomenological perspectives in psychology. Plenum Press, New York, pp 41–60CrossRef
38.
Creswell JW (1998) Qualitative inquiry and research design: choosing among five traditions. Sage Publications, Thousand Oaks
39.
Sale JEM, Gignac M, Hawker G, Frankel L, Beaton D, Bogoch E et al (2012) Patients reject the concept of fragility fracture—a new understanding based on fracture patients' communication. Osteoporos Int 23(12):2829–34
40.
41.
42.
Siminoski K, Jiang G, Adachi JD, Hanley DA, Cline G, Ioannidis G et al (2005) Accuracy of height loss during prospective monitoring for detection of incident vertebral fractures. Osteoporos Int 16:403–10
43.
Allin S, Munce SSAM, Hawker G, Murphy K, Jaglal SB (2013) Quality of fracture risk assessment in post-fracture care in Ontario, Canada. Osteoporos Int 24:899–905PubMedCrossRefPubMedCentral
44.
Kingwell E, Prior JC, Ratner PA, Kennedy SM (2010) Direct-to-participant feedback and awareness of bone mineral density testing results in a population-based sample of mid-aged Canadians. Osteoporos Int 21:307–19PubMedCrossRef
45.
46.
Beaton D, Mamdani M, Zheng H, Jaglal S, Cadarette S, Jain R et al (2013) Impact of a case finding intervention on fracture risk reduction outcomes following fragility fractures. The 2nd Fragility Fracture Network Global Congress, Berlin
47.
Summerskill WSM, Pope C (2002) I saw the panic in her eyes, and evidence-based medicine went out of the door. An exploratory qualitative study of the barriers to secondary prevention in the management of coronary heart disease. Fam Pract 19(6):605–10PubMedCrossRef
Metadata
Title
Patient perceptions of provider barriers to post-fracture secondary prevention
Authors
J. E. M. Sale
E. Bogoch
G. Hawker
M. Gignac
D. Beaton
S. Jaglal
L. Frankel
Publication date
01-11-2014
Publisher
Springer London
Published in
Osteoporosis International / Issue 11/2014
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-014-2804-4

Other articles of this Issue 11/2014

Osteoporosis International 11/2014 Go to the issue

Original Article

Impact of multidisciplinary hip fracture program on timing of surgery in elderly patients

Letter

Comment on Tadrous et al.: Comparative gastrointestinal safety of bisphosphonates in primary osteoporosis: a network meta-analysis

Original Article

Physical activity and 10-year incidence of self-reported vertebral fractures in Japanese women: The Japan Public Health Center-based Prospective Study

Original Article

Bone status and fractures in 85 adults with Wilson’s disease

Original Article

Adiponectin is associated with bone strength and fracture history in paralyzed men with spinal cord injury

Review

Management of osteoporosis of the oldest old